-
1
-
-
0026681119
-
Prevalence of age-related maculopathy: The beaver dam eye study
-
Klein R, Klein BEK, Linton KLP. Prevalence of age-related maculopathy: the Beaver Dam Eye study. Ophthalmology 99, 933-943 (1992).
-
(1992)
Ophthalmology
, vol.99
, pp. 933-943
-
-
Klein, R.1
Klein, B.E.K.2
Linton, K.L.P.3
-
2
-
-
0000180036
-
Subretinal neovascularization
-
Ryan SJ Ed. St. Louis MO USA
-
Ryan SJ, Stout JT, Dugel PU. Subretinal neovascularization. In:Retina . Ryan SJ (Ed.). St. Louis, MO, USA, 1027-1047 (1994).
-
(1994)
Retina
, pp. 1027-1047
-
-
Ryan, S.J.1
Stout, J.T.2
Dugel, P.U.3
-
3
-
-
33749445317
-
Marina study group: Ranibizumab for neovascular age-related macular degeneration
-
Rosenfeld PJ, Brown DM, Heier JS et al. MARINA Study Group: ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355, 1419-1431 (2006).
-
(2006)
N. Engl. J. Med.
, vol.355
, pp. 1419-1431
-
-
Rosenfeld, P.J.1
Brown, D.M.2
Heier, J.S.3
-
4
-
-
33749451356
-
Anchor study group: Ranibizumab versus verteporfin for neovascular age-related macular degeneration
-
Brown DM, Kaiser PK, Michels M et al. ANCHOR Study Group: ranibizumab versus verteporfin for neovascular age-related macular degeneration. N. Engl. J. Med. 355, 1432-1444 (2006).
-
(2006)
N. Engl. J. Med.
, vol.355
, pp. 1432-1444
-
-
Brown, D.M.1
Kaiser, P.K.2
Michels, M.3
-
5
-
-
77953248909
-
Medical devices for the treatment of eye diseases
-
Yasukawa T, Ogura Y. Medical devices for the treatment of eye diseases. Handb. Exp. Pharmacol. 197, 469-489 (2010).
-
(2010)
Handb. Exp. Pharmacol.
, vol.197
, pp. 469-489
-
-
Yasukawa, T.1
Ogura, Y.2
-
6
-
-
79954446082
-
Recent advances in intraocular drug delivery systems
-
Yasukawa T, Tabata Y, Kimura H, Ogura Y. Recent advances in intraocular drug delivery systems. Recent Pat. Drug Deliv. Formul. 5, 1-10 (2011).
-
(2011)
Recent Pat. Drug Deliv. Formul.
, vol.5
, pp. 1-10
-
-
Yasukawa, T.1
Tabata, Y.2
Kimura, H.3
Ogura, Y.4
-
7
-
-
0002611505
-
Ocular pharmacokinetics
-
Sears ML Ed. Springer NY USA
-
Maurice DM, Mishima S. Ocular pharmacokinetics. In:Pharmacology of the Eye . Sears ML (Ed.). Springer, NY, USA, 19-116 (1984).
-
(1984)
Pharmacology of the Eye
, pp. 19-116
-
-
Maurice, D.M.1
Mishima, S.2
-
8
-
-
78649448567
-
Protein delivery for retinal diseases from basic considerations to clinical applications
-
El Sanharawi ME, Kowalczuk L, Touchard E, Omri S, de Kozak Y, Behar-Cohen F. Protein delivery for retinal diseases; from basic considerations to clinical applications. Prog. Retin. Eye Res. 29, 443-465 (2010).
-
(2010)
Prog. Retin. Eye Res.
, vol.29
, pp. 443-465
-
-
El Sanharawi, M.E.1
Kowalczuk, L.2
Touchard, E.3
Omri, S.4
De Kozak, Y.5
Behar-Cohen, F.6
-
9
-
-
0029347541
-
Ocular drug delivery: Conventional ocular formulations
-
Lang LC. Ocular drug delivery: conventional ocular formulations. Adv. Drug Deliv. Rev. 16, 39-43 (1995).
-
(1995)
Adv. Drug Deliv. Rev.
, vol.16
, pp. 39-43
-
-
Lang, L.C.1
-
10
-
-
47249126766
-
When nanotechnology meets the ocular surface
-
Bucolo C, Maltese, A, Drago F. When nanotechnology meets the ocular surface. Expert Rev. Ophthalmol. 3(3), 325-332 (2008).
-
(2008)
Expert Rev. Ophthalmol.
, vol.3
, Issue.3
, pp. 325-332
-
-
Bucolo, C.1
Maltese, A.2
Drago, F.3
-
11
-
-
79956218863
-
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
-
CATT Research Group:
-
CATT Research Group: Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GL. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 364, 1897-1908 (2011).
-
(2011)
N. Engl. J. Med.
, vol.364
, pp. 1897-1908
-
-
Martin, D.F.1
Maguire, M.G.2
Ying, G.S.3
Grunwald, J.E.4
Fine, S.L.5
Jaffe, G.L.6
-
12
-
-
0037143764
-
VEGF-Trap: A VEGF blocker with potent antitumor effects
-
USA
-
Holash J, Davis S, Papadopoulos N et al. VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc. Natl Acad. Sci. USA 99, 11393-11398 (2002).
-
(2002)
Proc. Natl Acad. Sci.
, vol.99
, pp. 11393-11398
-
-
Holash, J.1
Davis, S.2
Papadopoulos, N.3
-
13
-
-
75149190168
-
Adverse events after intravitreal infliximab remicade
-
Giganti M, Beer PM, Lemanski N, Hartman C, Schartman J, Falk N. Adverse events after intravitreal infliximab (Remicade). Retina 30, 71-80 (2010).
-
(2010)
Retina
, vol.30
, pp. 71-80
-
-
Giganti, M.1
Beer, P.M.2
Lemanski, N.3
Hartman, C.4
Schartman, J.5
Falk, N.6
-
14
-
-
2942536634
-
Drug delivery systems for vitreoretinal diseases
-
Yasukawa T, Ogura Y, Tabata Y, Kimura H, Wiedemann P, Honda Y. Drug delivery systems for vitreoretinal diseases. Prog. Retin. Eye Res. 23, 253-281 (2004).
-
(2004)
Prog. Retin. Eye Res.
, vol.23
, pp. 253-281
-
-
Yasukawa, T.1
Ogura, Y.2
Tabata, Y.3
Kimura, H.4
Wiedemann, P.5
Honda, Y.6
-
15
-
-
0033951011
-
Experimental corneal neovascularization by basic fibroblast growth factor impregnated in gelatin hydrogel
-
Yang CF, Yasukawa T, Kimura H et al. Experimental corneal neovascularization by basic fibroblast growth factor impregnated in gelatin hydrogel. Ophthalmic Res. 32, 19-24 (2000).
-
(2000)
Ophthalmic Res.
, vol.32
, pp. 19-24
-
-
Yang, C.F.1
Yasukawa, T.2
Kimura, H.3
-
16
-
-
61549121751
-
Initial bone regeneration around fenestrated implants in Beagle dogs using basis fibroblast growth factor-gelatin hydrogel complex with varying biodegradation rates
-
Akagawa Y, Kubo T, Koretake K et al. Initial bone regeneration around fenestrated implants in Beagle dogs using basis fibroblast growth factor-gelatin hydrogel complex with varying biodegradation rates. J. Prosthodont. Res. 53, 41-47 (2009).
-
(2009)
J. Prosthodont. Res.
, vol.53
, pp. 41-47
-
-
Akagawa, Y.1
Kubo, T.2
Koretake, K.3
-
18
-
-
33744801076
-
Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomized eye
-
Kosobucki BR, Freeman WR, Cheng L. Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomized eye. Br. J. Ophthalmol. 90, 705-708 (2006).
-
(2006)
Br. J. Ophthalmol.
, vol.90
, pp. 705-708
-
-
Kosobucki, B.R.1
Freeman, W.R.2
Cheng, L.3
-
19
-
-
85028109108
-
Sustained release of a monoclonal antibody from electrochemically prepared porous silica for the treatment of age related macular degeneration
-
E-Abstract 3488
-
Andrew JS, Anglin EJ, Cunin F et al. Sustained release of a monoclonal antibody from electrochemically prepared porous silica for the treatment of age related macular degeneration. Invest. Ophthalmol. Vis. Sci. 50 (2009) (E-Abstract 3488).
-
(2009)
Invest. Ophthalmol. Vis. Sci.
, vol.50
-
-
Andrew, J.S.1
Anglin, E.J.2
Cunin, F.3
-
20
-
-
82455180476
-
Resorbable sustained intra-ocular release system for monoclonal antibodies and other large molecules
-
E-Abstract 5333
-
Hampton SM, Voigt A, Reiff A. Resorbable sustained intra-ocular release system for monoclonal antibodies and other large molecules. Invest. Ophthalmol. Vis. Sci. 51, (2010) (E-Abstract 5333).
-
(2010)
Invest. Ophthalmol. Vis. Sci.
, vol.51
-
-
Hampton, S.M.1
Voigt, A.2
Reiff, A.3
-
21
-
-
26844530250
-
Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels
-
Burdick JA, Ward M, Liang E, Young MJ, Langer R. Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels. Biomaterials 27, 452-459 (2006).
-
(2006)
Biomaterials
, vol.27
, pp. 452-459
-
-
Burdick, J.A.1
Ward, M.2
Liang, E.3
Young, M.J.4
Langer, R.5
-
22
-
-
69249222639
-
New formulation of vasoactive intestinal peptide using liposomes in hyaluronic acid gel for uveitis
-
Lajavardi L, Camelo S, Agnely F et al. New formulation of vasoactive intestinal peptide using liposomes in hyaluronic acid gel for uveitis. J. Control Release 139, 22-30 (2009).
-
(2009)
J. Control Release
, vol.139
, pp. 22-30
-
-
Lajavardi, L.1
Camelo, S.2
Agnely, F.3
-
23
-
-
79952118241
-
Suppression of drusen formation by compstatin a peptide inhibitor of complement C3 activation on cynomolgus monkey with early-onset macular degeneration
-
Chi ZL, Yoshida T, Lambris JD, Iwata T. Suppression of drusen formation by compstatin, a peptide inhibitor of complement C3 activation, on cynomolgus monkey with early-onset macular degeneration. Adv. Exp. Med. Biol. 703, 127-135 (2010).
-
(2010)
Adv. Exp. Med. Biol.
, vol.703
, pp. 127-135
-
-
Chi, Z.L.1
Yoshida, T.2
Lambris, J.D.3
Iwata, T.4
-
24
-
-
8544270082
-
Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration results of a prospective randomized placebo-controlled clinical trial
-
Pharmacological Therapy for Macular Degeneration Study Group
-
Pharmacological Therapy for Macular Degeneration Study Group. Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Arch. Ophthalmol. 115, 865-872 (1997).
-
(1997)
Arch. Ophthalmol.
, vol.115
, pp. 865-872
-
-
-
25
-
-
0036750664
-
Pegylated interferons for the treatment of chronic hepatitis C infection
-
Luxon BA, Grace M, Brassard D, Bordens R. Pegylated interferons for the treatment of chronic hepatitis C infection. Clin. Ther. 24, 1363-1383 (2002).
-
(2002)
Clin. Ther.
, vol.24
, pp. 1363-1383
-
-
Luxon, B.A.1
Grace, M.2
Brassard, D.3
Bordens, R.4
-
26
-
-
0022858683
-
A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
-
Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46, 6387-6392 (1986).
-
(1986)
Cancer Res.
, vol.46
, pp. 6387-6392
-
-
Matsumura, Y.1
Maeda, H.2
-
27
-
-
0036184270
-
Targeting of interferon to choroidal neovascularization by use of dextran and metal coordination
-
Yasukawa T, Kimura H, Tabata Y et al. Targeting of interferon to choroidal neovascularization by use of dextran and metal coordination. Invest. Ophthalmol. Vis. Sci. 43, 842-848 (2002).
-
(2002)
Invest. Ophthalmol. Vis. Sci.
, vol.43
, pp. 842-848
-
-
Yasukawa, T.1
Kimura, H.2
Tabata, Y.3
-
28
-
-
2342586114
-
Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470
-
Satchi-Fainaro R, Puder M, Davies JW et al. Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. Nat. Med. 10, 255-261 (2004).
-
(2004)
Nat. Med.
, vol.10
, pp. 255-261
-
-
Satchi-Fainaro, R.1
Puder, M.2
Davies, J.W.3
-
29
-
-
0034442273
-
Active drug targeting with immunoconjugates to choroidal neovascularization
-
Yasukawa T, Kumura H, Tabata Y et al. Active drug targeting with immunoconjugates to choroidal neovascularization. Curr. Eye Res. 21, 952-961 (2000).
-
(2000)
Curr. Eye Res.
, vol.21
, pp. 952-961
-
-
Yasukawa, T.1
Kumura, H.2
Tabata, Y.3
-
30
-
-
0034793589
-
Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat
-
Kamizuru H, Kimura H, Yasukawa T, Tabata Y, Honda Y, Ogura Y. Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat. Invest. Ophthalmol. Vis. Sci. 42, 2664-2672 (2001).
-
(2001)
Invest. Ophthalmol. Vis. Sci.
, vol.42
, pp. 2664-2672
-
-
Kamizuru, H.1
Kimura, H.2
Yasukawa, T.3
Tabata, Y.4
Honda, Y.5
Ogura, Y.6
-
31
-
-
0029843947
-
Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases
-
USA
-
Friedlander M, Theesfeld CL, Sugita M et al. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc. Natl Acad. Sci. USA 93, 9764-9769 (1996).
-
(1996)
Proc. Natl Acad. Sci.
, vol.93
, pp. 9764-9769
-
-
Friedlander, M.1
Theesfeld, C.L.2
Sugita, M.3
-
32
-
-
0032961301
-
Expression of vascular endothelial growth factor and its receptor KDR/flk-1 mRNA in experimental choroidal neovascularization
-
Wada M, Ogata N, Otsuji T, Uyama M. Expression of vascular endothelial growth factor and its receptor (KDR/flk-1) mRNA in experimental choroidal neovascularization. Curr. Eye. Res. 18, 203-213 (1999).
-
(1999)
Curr. Eye. Res.
, vol.18
, pp. 203-213
-
-
Wada, M.1
Ogata, N.2
Otsuji, T.3
Uyama, M.4
-
33
-
-
0038147049
-
Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization
-
Sakurai E, Taguchi H, Anand A et al. Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 44, 2743-2749 (2003).
-
(2003)
Invest. Ophthalmol. Vis. Sci.
, vol.44
, pp. 2743-2749
-
-
Sakurai, E.1
Taguchi, H.2
Anand, A.3
-
34
-
-
0031657921
-
Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularization in the rat
-
Shen WY, Yu MJ, Barry CJ, Constable IJ, Rakoczy PE. Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularization in the rat. Br. J. Ophthalmol. 82, 1063-1071 (1998).
-
(1998)
Br. J. Ophthalmol.
, vol.82
, pp. 1063-1071
-
-
Shen, W.Y.1
Yu, M.J.2
Barry, C.J.3
Constable, I.J.4
Rakoczy, P.E.5
-
35
-
-
67650457597
-
CCR3 is a target for age-related macular degeneration diagnosis and therapy
-
Takeda A, Baffi JZ, Kleinman ME et al. CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 460, 225-230 (2009).
-
(2009)
Nature
, vol.460
, pp. 225-230
-
-
Takeda, A.1
Baffi, J.Z.2
Kleinman, M.E.3
-
36
-
-
82455221503
-
Sustained intraocular delivery of a receptor antibody using an encapsulated cell technology implant
-
E-Abstract 5317
-
Kauper K, Stabila P, Elliot S et al. Sustained intraocular delivery of a receptor antibody using an encapsulated cell technology implant. Invest. Ophthalmol. Vis. Sci. 51 (2010) (E-Abstract 5317).
-
(2010)
Invest. Ophthalmol. Vis. Sci.
, vol.51
-
-
Kauper, K.1
Stabila, P.2
Elliot, S.3
-
37
-
-
79955128744
-
Nuclear targeted delivery of macromolecules to retina and cornea
-
Binder C, Read SP, Cashman SM, Kumar-Singh R. Nuclear targeted delivery of macromolecules to retina and cornea. J. Gene Med. 13, 158-170 (2011).
-
(2011)
J. Gene Med.
, vol.13
, pp. 158-170
-
-
Binder, C.1
Read, S.P.2
Cashman, S.M.3
Kumar-Singh, R.4
-
39
-
-
75749121523
-
Suppression of ICAM-1 in retinal and choroidal endothelial cells by plasmid small-interfering RNAs in vivo
-
Hirano Y, Sakurai E, Matsubara A, Ogura Y. Suppression of ICAM-1 in retinal and choroidal endothelial cells by plasmid small-interfering RNAs in vivo. Invest. Ophthalmol. Vis. Sci. 51, 508-515 (2010).
-
(2010)
Invest. Ophthalmol. Vis. Sci.
, vol.51
, pp. 508-515
-
-
Hirano, Y.1
Sakurai, E.2
Matsubara, A.3
Ogura, Y.4
-
40
-
-
77949423366
-
Inhibitory efficacy of hypoxia-inducible factor 1alpha short hairpin RNA plasmid DNA-loaded poly d l-lactide-co-glycolide nanoparticles on choroidal neovascularization in a laser-induced rat model
-
Zhang C, Wang YS, Wu H et al. Inhibitory efficacy of hypoxia-inducible factor 1alpha short hairpin RNA plasmid DNA-loaded poly (d, l-lactide-co- glycolide) nanoparticles on choroidal neovascularization in a laser-induced rat model. Gene Ther. 17, 338-351 (2010).
-
(2010)
Gene Ther.
, vol.17
, pp. 338-351
-
-
Zhang, C.1
Wang, Y.S.2
Wu, H.3
-
41
-
-
11144232135
-
Sustained secretion of ciliary neurotrophic factor to the vitreous using the encapsulated cell therapy-based NT-501 intraocular device
-
Thanos CG, Bell WJ, O'Rourke P et al. Sustained secretion of ciliary neurotrophic factor to the vitreous, using the encapsulated cell therapy-based NT-501 intraocular device. Tissue Eng. 10, 1617-1622 (2004).
-
(2004)
Tissue Eng.
, vol.10
, pp. 1617-1622
-
-
Thanos, C.G.1
Bell, W.J.2
O'Rourke, P.3
|